BioCentury | Oct 6, 2008
Clinical News
Xalieve physostigmine: Phase II started
...while the second double-blind portion will evaluate a single dose strength applied 4 times daily. Calabar AB...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
